openPR Logo
Press release

Irritable Bowel Syndrome with Constipation Market (IBS-C): Industry Survey and Industry Outlook 2022 by Credence Research

01-03-2017 07:55 PM CET | Health & Medicine

Press release from: credence research

Irritable Bowel Syndrome with Constipation Market (IBS-C):

As stated in a latest study published by Credence Research, Inc. “Global Irritable Bowel Syndrome with Constipation Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” higher prevalence of IBS in developed world and prompt address to the need for advanced pharmaceutical measures will facilitate the dominance of Europe IBS-C drugs market on the global front.
IBS is prevalent in general population across the globe for a long period and has affected adversely in terms of medical costs and socioeconomic impact. Increased prevalence of lifestyle related diseases, growth in healthcare spending, augmented patient population suffering from gastrointestinal diseases and medical advancements are the prime contributors to the growth of IBS-C drugs market.
Browse the full report Irritable Bowel Syndrome with Constipation (IBS-C) Drugs Market http://www.credenceresearch.com/report/irritable-bowel-syndrome-with-constipation-drugs-market
Europe is a combination of varied market trends mutually prevalent across the comprising countries, attributed by the cultural mix and healthcare infrastructures. The region has the largest share in the global IBS-C drugs market and was valued at USD 445.7 Mn in 2015. As IBS patient pool is the highest in the region, the demand for treatment options is also correspondingly high. The prevalence of IBS in European countries ranges from 5% to 25%.
IBS and CI are the two most common gastrointestinal disorders in North America. The conditions together affect more than 30 Million individuals as of 2014. North America also has the highest count of patients suffering from constipation. Evolved healthcare infrastructure, early bird commercialization of IBS-C drugs in the US, better reimbursement policies and higher awareness among both physicians and patient population are the major contributors to the dominance of North America in the global market.
In addition, Asia Pacific is expected to open further avenues for the international players in IBS-C market. APAC is emerging region with the huge scope for the pharmaceutical companies. Japan and China in particular are considered to be very promising countries for drugs market. As Asia is home to half of the world's population, and offers both a large relatively low-cost workforce in some countries and a potentially huge retail market, this region could be central to the future of the global economy.
APAC is the third largest market for the drugs of IBS are many big pharmaceutical companies are investing in for future growth. The number of patients suffering from irritable bowel syndrome accounts to almost 7% of the population. China has the largest market share for the drugs manufacturers in this region as this is one of the most potential markets for pharmaceutical giants and largest number of patients after Japan.

Request Sample: http://www.credenceresearch.com/sample-request/57749
Related Reports:
http://www.credenceresearch.com/report/opioid-induced-constipation-oic-drugs-market
http://www.credenceresearch.com/report/opioid-induced-constipation-oic-drugs-market
http://www.credenceresearch.com/report/chronic-idiopathic-constipation-cic-drugs-market

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com

About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

105 N 1st ST #429, SAN JOSE,
CA 95103, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Irritable Bowel Syndrome with Constipation Market (IBS-C): Industry Survey and Industry Outlook 2022 by Credence Research here

News-ID: 404902 • Views:

More Releases from credence research

Pharmacy Market Size, Growth | Industry Report, 2023-2032
Pharmacy Market Size, Growth | Industry Report, 2023-2032
The latest market report published by Credence Research, Inc. The demand for the US Retail Pharmacy Market, valued at USD 569.79 Billion in 2023, is projected to soar to USD 948.80 Billion by 2032, marking a robust compound annual growth rate (CAGR) of 5.76% during the period from 2024 to 2032. The US retail pharmacy market stands as a cornerstone of the nation's healthcare infrastructure, serving as the frontline for patient
Medical Headgears Market is Expected to Reach USD 2,184.62 million by 2032 | Credence Research
Medical Headgears Market is Expected to Reach USD 2,184.62 million by 2032 | Cre …
The Medical Headgears Market is poised for substantial growth, with a market value of USD 1,247.86 million in 2024 projected to surge to USD 2,184.62 million by 2032, representing a robust compound annual growth rate (CAGR) of 6.36%. In the realm of healthcare, innovation is key, and this holds true for the field of medical headgears. These devices play a crucial role in various medical applications, from orthodontics to craniofacial
Quality Management Software Market Size, Share, Analysis, Growth & Forecast 2030
Quality Management Software Market Size, Share, Analysis, Growth & Forecast 2030
The latest market report published by Credence Research, Inc. The global demand for Quality Management Software market was valued at USD 9654.8 Million in 2023 and is expected to reach USD 24697.3 Million in 2032, growing at a CAGR of 11.00% between 2024 and 2032. In today's fast-paced and highly competitive business landscape, ensuring the highest level of product or service quality is paramount. Quality management is not just a goal
Commercial Drone Market Size, Growth to Reach USD 56756.3 Million by 2030 | Credence Research
Commercial Drone Market Size, Growth to Reach USD 56756.3 Million by 2030 | Cred …
The latest market report published by Credence Research, Inc. The global demand for Commercial Drone was valued at USD 19482.5 Million in 2022 and is expected to reach USD 56756.3 Million in 2030, growing at a CAGR of 14.30% between 2023 and 2030. In recent years, the commercial drone market has experienced exponential growth, revolutionizing industries and opening up new possibilities for businesses across the globe. From agriculture and construction to

All 5 Releases


More Releases for IBS

Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs. 👉 Download our latest market insights:
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide. A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L
HaCon and IBS combine expertise in railway operation
Hanover (2010-07-06). Two Hanoverian companies now combine their expertise in questions of railway operations: With effect from 1 July 2010, the HaCon Ingenieurgesellschaft mbH, took over the engineering firm for railway operating systems (Ingenieurbüro für Bahnbetriebssysteme GmbH – IBS). This way HaCon expanded its services to include the areas operation simulation, vehicle and personnel planning and construction operations planning. This also includes consulting services concerning railway systems issues, such as travel
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011. The new bulkers, each with a capacity of 176,000 dwt, will be equipped